本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corvus Pharmaceuticals, Inc.

12.91
-0.0300-0.23%
盤後12.910.00000.00%19:30 EDT
成交量:125.76萬
成交額:1,629.46萬
市值:10.81億
市盈率:-20.65
高:13.50
開:13.13
低:12.77
收:12.94
52周最高:26.95
52周最低:5.64
股本:8,376.77萬
流通股本:7,412.01萬
量比:1.31
換手率:1.70%
股息:- -
股息率:- -
每股收益(TTM):-0.6252
每股收益(LYR):-0.5320
淨資產收益率:-35.43%
總資產收益率:-21.66%
市淨率:4.80
市盈率(LYR):-24.27

資料載入中...

2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/01

重要事件披露

Form 8-K - Current report
2024/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

重要事件披露

Form 8-K - Current report
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/08

重要事件披露

Form 8-K - Current report